Arran Attridge

SENIOR VICE PRESIDENT, CORPORATE COMMUNICATIONS

Arran Attridge has served as Vir’s Senior Vice President of Corporate Communications since July 2024. Ms. Attridge is responsible for leading communications, patient advocacy and stakeholder engagement for Vir. She has over two decades of experience as a public relations and advocacy leader, guiding communications strategy through pre-clinical and clinical development, regulatory review, launch and in-market access across a range of therapeutic areas.

Prior to joining Vir, Ms. Attridge served as Vice President at CymaBay Therapeutics where she led corporate communications in preparation for commercialization and through the acquisition of the company. Prior to that, Ms. Attridge served over a decade at Gilead Sciences where she held roles of increasing responsibility in the U.S. and Europe. During her tenure at Gilead, she led communications across HIV, viral hepatitis (B, C and delta), COVID-19, liver diseases, inflammation, emerging viruses and cancers. She served for over nine years as a public relations consultant to the pharmaceutical industry with a focus on corporate reputation, advocacy and product commercialization.

Ms. Attridge completed her Bachelor of Science degree in genetics with a year in industry, from the University of York in the U.K. and holds a professional certificate from the U.K. Chartered Institute of Marketing.